Colorectal cancer adjuvant treatment in elderly patients

Lara Maria Pasetto, Elena Rossi, Antonio Jirillo, Silvio Monfardini

Research output: Contribution to journalArticlepeer-review


Colorectal adenocarcinoma ranks second as a cause of death due to cancer in the Western world. In Europe, 40% of patients with this disease is over 70 years old and only 52% of them with positive nodes usually receive an adjuvant chemotherapy. Despite early reports to the contrary, these patients tolerate cancer treatment and surgical resections as well as their younger counterparts but as a result of exclusion criteria, those receiving an adjuvant therapy are very few. This paper examines the factors pertinent to the small number of clinical trials designed for adjuvant colorectal cancer in the elderly.

Original languageEnglish
Pages (from-to)201-206
Number of pages6
JournalCritical Reviews in Oncology/Hematology
Issue number3
Publication statusPublished - Sep 2005


  • Adjuvant
  • Chemotherapy
  • Colorectal cancer
  • Elderly
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Colorectal cancer adjuvant treatment in elderly patients'. Together they form a unique fingerprint.

Cite this